This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: International Aids Vaccine Initiative. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Joseph G. Jardine and His HIV Vaccine Patent
Introduction
Joseph G. Jardine is an inventor associated with La Jolla, California. His patent work concerns antibodies that bind HIV gp120 and methods for using them.
Latest Patents
Jardine is listed as an inventor on one patent: “Antibodies Capable of Binding HIV gp120 and Methods of Use Thereof.” The patent focuses on antibodies that target gp120, a protein on the surface of HIV, and methods for applying those antibodies.
Career Highlights
Jardine is associated with the International AIDS Vaccine Initiative. His listed patent reflects work in HIV-related antibody research and vaccine development.
Collaborations
Jardine is listed alongside fellow inventor Dennis R. Burton on the patent, indicating a collaboration in research involving HIV-targeting antibodies.
Conclusion
Joseph G. Jardine’s patent contribution centers on antibodies that bind HIV gp120, connecting his inventive work with research efforts at the International AIDS Vaccine Initiative.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile